Skip to main content

Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges

Moderna's decision aligns with its broader effort to cut costs by resizing its Covid vaccine manufacturing footprint.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.